Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 338, Issue 5, pp 567–572 | Cite as

Characteristics of β-endorphin-induced histamine release from rat serosal mast cells Comparison with neurotensin, dynorphin and compound 48/80

  • Anita Sydbom
Article

Summary

Rat peritoneal mast cells were exposed to the neurohormone and basic opioid peptide β-endorphin. β-Endorphin induced a dose-dependent release of histamine from the mast cells. A significant histamine release was found at 5 μmol/l of β-endorphin and maximal release (35% of total) at 20 μmol/l. The histamine release process was very rapid and terminated within 30 s at 37°C, and in this sense is very similar to the histamine release induced by compound 48/80 or neurotensin. The histamine release was temperature-dependent showing an optimum release around 30°C, and it was independent of available extracellular calcium, but was inhibited in the presence of high extracellular calcium concentrations. Naloxone, only in very high concentrations (10 mmol/l), inhibited the release, and the very same concentration also inhibited the neurotensin — as well as the compound 48/80-induced histamine release. Cromoglycate and benzalkoniumchloride, a 48/80 antagonist, both produced a progressive dose-dependent inhibition of β-endorphin-, neurotensin- as well as compound 48/80-induced histamine release. Taken together, the findings indicate that the opioid peptide β-endorphin induces a selective, energy-dependent release of histamine from peritoneal rat mast cells. The pattern of release has much in common with that of compound 48/80 and other basic peptides, such as neurotensin and substance P. In addition this pattern of release is similar to that induced by dynorphin.

Key words

Histamine liberation Peritoneal mast cells Neuropeptides β-Endorphin Compound 48/80 Neurotensin Substance P Naloxone Disodiumcromoglycate Benzalkoniumchloride 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Atkinson G, Ennis E, Pearce FL (1979) The effect of alkaline earth cations on the release of histamine from rat peritoneal mast cells treated with compound 48/80 and peptide 401. Br J Pharmacol 65:395–402CrossRefGoogle Scholar
  2. Bergendorff A, Uvnäs B (1972) Storage of 5-hydroxytryptamine in rat mast cells. Evidence for an ionic binding to carboxyl groups in a granule heparin-protein complex. Acta Physiol Scand 84:320–331CrossRefGoogle Scholar
  3. Brandt NJ, Terenius L, Jacobsen BB, Klinken L, Nordius Å, Brandt S, Blegvad K, Yssing M (1980) Hyper-endorphin syndrome in a child with necrotizing encephalomyelopathy. New Engl J Med 303:914–916CrossRefGoogle Scholar
  4. McCain HW, Lamster IB, Bilotta J (1986) Modulation of human T-cell suppressor activity by beta endorphin and glycyl-l-glutamine. Int J Immunopharmacol 8:443–446CrossRefGoogle Scholar
  5. De Carolis C, De Sanctis G, Perricone R, Moretti C, Fabbri A, Gnessi L, Fraioli F, Fontana L (1984) Evidence for an inhibitory role of β-endorphin and other opioids on human total T rosette formation. Experentia 40:738–739CrossRefGoogle Scholar
  6. Chahl LA (1979) The effect of putative peptide neurotransmitters on cutaneous vascular permeability in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 309:159–163CrossRefGoogle Scholar
  7. Fewtrell CMS, Foreman JC, Jordan CC, Oehme P, Renner H, Stewart JM (1982) The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol 330:393–411CrossRefGoogle Scholar
  8. Fischer EG, Falke NE (1984) β-endorphin modulates immune functions. Psychother Psychosom 42:195–204CrossRefGoogle Scholar
  9. Foreman JC (1981) The pharmacological control of immediate hypersensitivity. Ann Rev Pharmacol Toxicol 21:63–81CrossRefGoogle Scholar
  10. Goldstein DJ, Keiser HR (1983) A case of episodic flushing and organic psychosis: Reversal by opiate antagonists. Ann Internal Med 98:30–34CrossRefGoogle Scholar
  11. Goth A (1967) Effect of drugs on mast cells. Adv Pharmacol 5:47–78CrossRefGoogle Scholar
  12. Grosman N (1981) Histamine release from isolated rat mast cells: Effect of morphine and related drugs and their interaction with compound 48/80. Agents and Actions 11:196–203CrossRefGoogle Scholar
  13. Holaday JW, Faden AI (1978) Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 275:450–451CrossRefGoogle Scholar
  14. Imura H, Nakai Y (1981) “Endorphins” in pituitary and other tissues. Ann Rev Physiol 43:265–278CrossRefGoogle Scholar
  15. Ishizaka K, Ishizaka T (1969) Immune mechanisms of reversed type reaginic hypersensitivity. J Immunol 103:588–595PubMedGoogle Scholar
  16. Jasani B, Kreil G, Mackler BF, Stanworth DR (1979) Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells. Biochem J 181:623–632CrossRefGoogle Scholar
  17. Johnson AR, Moran NC (1969) Selective release of histamine from rat mast cells by compound 48/80 and antigen. Am J Physiol 216:453–459CrossRefGoogle Scholar
  18. Johnson AR, Erdfis EG (1973) Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med 142:1252–1256CrossRefGoogle Scholar
  19. Kay N, Allen J, Morley JE (1984) Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci 35:53–59CrossRefGoogle Scholar
  20. Kazimierczak W, Diamant B (1978) Mechanisms of histamine release in anaphylactic and anaphylactoid reaction. Prog Allergy 24:295–365PubMedGoogle Scholar
  21. Krüger PG, Aas P, Onarheim J, Helle KB (1982) Neurotensin-induced release of histamine from rat mast cells in vitro. Acta Physiol Scand 114:467–469CrossRefGoogle Scholar
  22. Kurose M, Saeki K (1981) Histamine release induced by neurotensin from rat peritoneal mast cells. Europ J Pharmacol 76:129–136CrossRefGoogle Scholar
  23. Lembeck F, Holzer P (1979) Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 310:175–183CrossRefGoogle Scholar
  24. Mathews PM, Froelich CJ, Sibbitt WL Jr, Bankhurst AD (1983) Enhancement of natural cytotoxicity by β-endorphin. J Immunol 130:1658–1662PubMedGoogle Scholar
  25. Nordlind K, Mutt V (1986) Modulating effect of beta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of peripheral blood T lymphocytes of nickel-allergic patients to nickel sulfate. Int Arch Allergy Appl Immunol 81:368–370CrossRefGoogle Scholar
  26. Quirion R, Rioux F, Regoli D, St.-Pierre S (1980) Compound 48/80 inhibits neurotensin-induced hypotension in rats. Life Sci 27:1889–1895CrossRefGoogle Scholar
  27. Read GW, Kiefer EF (1979) Benzalkonium chloride: Selective inhibitor of histamine release induced by compound 48/80 and other polyamines. J Pharmacol Exp Ther 211:711–715PubMedGoogle Scholar
  28. Read GW, Lenney JF (1972) Molecular weight studies on the active constituents of compound 48/80. J Med Chem 15:320–323CrossRefGoogle Scholar
  29. Rosell S, Rökaeus Å (1981) Actions and possible hormonal functions of circulating neurotensin. Clin Physiol 1:3–20CrossRefGoogle Scholar
  30. Rossie SS, Miller RJ (1982) Regulation of mast cell histamine release by neurotensin. Life Sci 31:509–516CrossRefGoogle Scholar
  31. Shanahan F, Lee TDG, Bienenstock J, Befus AD (1984) The influence of endorphins on peritoneal and mucosal mast cell secretion. J Allergy Clin Immunol 74:499–504CrossRefGoogle Scholar
  32. Shibata H, Mio M, Tasaka K (1985) Analysis of the mechanism of histamine release induced by substance P. Biochim Biophys Acta 846:1–7CrossRefGoogle Scholar
  33. Shore PA, Burkhalter A, Cohn VH Jr (1959) A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 127:182–186Google Scholar
  34. Sugiyama K, Furuta H (1984) Histamine release induced by dynorphin-(1–13) from rat mast cells. Jpn J Pharmacol 35:247–252CrossRefGoogle Scholar
  35. Sydbom A (1982) Histamine release from isolated rat mast cells by neurotensin and other peptides. Agents and Actions 12:91–93CrossRefGoogle Scholar
  36. Sydbom A (1987) Effects of β-endorphin on rat mast cells. European Histamine Res See XVIth Meeting, Strbske' Pleso, May 20–24, 1987Google Scholar
  37. Sydbom A, Fredholm BB (1982) On the mechanism by which theophylline inhibits histamine release from rat mast cells. Acta Physiol Scand 114:243–251CrossRefGoogle Scholar
  38. Sydbom A, Terenius L (1985) The histamine-releasing effect of dynorpin and other peptides possessing Arg-Pro sequences. Agents and Actions 16:269–272CrossRefGoogle Scholar
  39. Thompson JW (1984) Opioid peptides. Br Med J 288:259–261CrossRefGoogle Scholar
  40. Uvnäs B, Thou I-L (1961) Evidence for enzymatic histamine release from isolated mast cells. Exp Cell Res 23:45–57CrossRefGoogle Scholar
  41. Watson RR, Jackson JC, Hartmann B, Sampliner R, Mobley D, Eskelson C (1985) Cellular immune fractions, endorphins, and alcohol consumption in males. Alcoholism (NY) 9:248–254CrossRefGoogle Scholar
  42. White JR, Ishizaka T, Ishizaka K, Sha'afi RI (1984) Direct demonstration of increased intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cell. Proc Natl Acad Sci USA 81:3978–3982CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • Anita Sydbom
    • 1
  1. 1.Department of PharmacologyKarolinska InstitutStockholmSweden

Personalised recommendations